Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker MNPR
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 12, 2026 | MNPR Monopar Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 12, 2026 | MNPR Monopar Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 22, 2026 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 30, 2026 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 26, 2026 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 23, 2026 | MNPR Monopar Therapeutics Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 29, 2026 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 19, 2026 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 14, 2026 | MNPR Monopar Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 20, 2026 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 27, 2026 | MNPR Monopar Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 2, 2026 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 13, 2025 | MNPR Monopar Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 10, 2025 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 24, 2025 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 24, 2025 | MNPR Monopar Therapeutics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Sep 15, 2025 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 12, 2025 | MNPR Monopar Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 23, 2025 | MNPR Monopar Therapeutics Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 13, 2025 | MNPR Monopar Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 7, 2025 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 31, 2025 | MNPR Monopar Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 3, 2025 | MNPR Monopar Therapeutics Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 24, 2025 | MNPR Monopar Therapeutics Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 23, 2024 | MNPR Monopar Therapeutics Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Dec 23, 2024 | MNPR Monopar Therapeutics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 6, 2024 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 8, 2024 | MNPR Monopar Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 30, 2024 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 30, 2024 | MNPR Monopar Therapeutics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 24, 2024 | MNPR Monopar Therapeutics Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 24, 2024 | MNPR Monopar Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 24, 2024 | MNPR Monopar Therapeutics Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Oct 24, 2024 | MNPR Monopar Therapeutics Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Oct 24, 2024 | MNPR Monopar Therapeutics Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Oct 24, 2024 | MNPR Monopar Therapeutics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
36 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:11 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances